Hims & Hers Health, Inc. (NYSE:HIMS) Short Interest Up 7.8% in November

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) saw a large increase in short interest in November. As of November 30th, there was short interest totalling 42,620,000 shares, an increase of 7.8% from the November 15th total of 39,520,000 shares. Based on an average daily volume of 15,600,000 shares, the short-interest ratio is currently 2.7 days. Currently, 24.0% of the shares of the stock are sold short.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on HIMS shares. Deutsche Bank Aktiengesellschaft increased their target price on shares of Hims & Hers Health from $23.00 to $27.00 and gave the stock a "hold" rating in a research report on Wednesday, November 6th. Canaccord Genuity Group raised their price objective on Hims & Hers Health from $28.00 to $38.00 and gave the company a "buy" rating in a research note on Monday, December 2nd. Morgan Stanley began coverage on Hims & Hers Health in a research report on Tuesday. They set an "overweight" rating and a $42.00 target price for the company. TD Cowen reissued a "buy" rating and issued a $28.00 price target on shares of Hims & Hers Health in a research report on Wednesday, November 20th. Finally, Piper Sandler reaffirmed a "neutral" rating and set a $21.00 price objective (up from $18.00) on shares of Hims & Hers Health in a report on Tuesday, November 5th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $22.80.

Hims & Hers Health Price Performance

Shares of HIMS traded down $0.13 during mid-day trading on Tuesday, reaching $31.12. The company had a trading volume of 14,635,490 shares, compared to its average volume of 9,946,161. The company has a market capitalization of $6.80 billion, a P/E ratio of 70.73 and a beta of 1.25. Hims & Hers Health has a twelve month low of $8.09 and a twelve month high of $35.02. The company's 50-day moving average is $25.27 and its 200-day moving average is $21.14.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last issued its quarterly earnings data on Monday, November 4th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.26. Hims & Hers Health had a net margin of 8.19% and a return on equity of 10.97%. The firm had revenue of $401.56 million for the quarter, compared to analysts' expectations of $382.20 million. During the same period in the prior year, the firm earned ($0.04) earnings per share. The company's quarterly revenue was up 77.1% compared to the same quarter last year. As a group, equities analysts expect that Hims & Hers Health will post 0.29 EPS for the current fiscal year.

Insider Activity

In other news, insider Michael Chi sold 2,054 shares of the company's stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $33.56, for a total value of $68,932.24. Following the transaction, the insider now owns 184,947 shares in the company, valued at $6,206,821.32. This represents a 1.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Soleil Boughton sold 2,339 shares of the company's stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $20.41, for a total transaction of $47,738.99. Following the completion of the transaction, the insider now directly owns 172,274 shares in the company, valued at $3,516,112.34. This trade represents a 1.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,143,575 shares of company stock worth $27,724,979. Corporate insiders own 17.71% of the company's stock.

Institutional Trading of Hims & Hers Health

Hedge funds have recently modified their holdings of the stock. Nisa Investment Advisors LLC lifted its holdings in Hims & Hers Health by 679.2% in the second quarter. Nisa Investment Advisors LLC now owns 1,839 shares of the company's stock valued at $37,000 after buying an additional 1,603 shares during the period. Legacy Capital Group California Inc. bought a new stake in shares of Hims & Hers Health in the 2nd quarter valued at $1,699,000. Bank of New York Mellon Corp raised its stake in Hims & Hers Health by 67.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 678,602 shares of the company's stock worth $13,701,000 after buying an additional 273,473 shares during the period. State of Michigan Retirement System lifted its holdings in Hims & Hers Health by 177.8% during the second quarter. State of Michigan Retirement System now owns 500,000 shares of the company's stock worth $10,095,000 after acquiring an additional 320,000 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its holdings in Hims & Hers Health by 322.9% during the second quarter. Allspring Global Investments Holdings LLC now owns 52,312 shares of the company's stock worth $1,056,000 after acquiring an additional 39,943 shares in the last quarter. 63.52% of the stock is owned by institutional investors.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.